BMC2 Data on Coronary Intravascular Lithotripsy and Contemporary PCI Outcomes in Older Adults Presented at ACC Scientific Sessions 2023

A row of microphones on stands.
Elizabeth Horn

BMC2 data was featured in three posters at ACC Scientific Sessions 2023. Dr. Ashwini Kerkar presented “Contemporary PCI Outcomes in Older Adults in Michigan: An Update from BMC2” which concluded that the proportion of older adults undergoing percutaneous coronary intervention continues to increase, reflecting demographic changes in the population. Despite advances in interventional cardiology equipment and technique, increasing age continues to remain a risk factor for adverse procedural outcomes post PCI. 

Dr. Kerkar also presented “Outcomes of Contemporary PCI in Nonagenarians: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.” This poster outlined a study concluding that nearly 400 patients > 90 years old undergo PCI in Michigan every year and, despite improvements in PCI safety and technique, nonagenarians experience significantly higher mortality than patients < 90 years old.  

The co-authors of both of Dr. Kerkar’s posters are Devraj Sukul, Milan Seth, Michael A. Lauer, M. Chadi Alraies, Elizabeth Jane Pielsticker, Gerald C. Koenig, Mamas A. Mamas, and Hitinder S. Gurm.


Dr. Devraj Sukul presented, “The Real-World Safety and Effectiveness of Coronary Intravascular Lithotripsy: Insights from the BMC2 Registry”. The study concludes that, since its FDA approval in February 2021, the use of coronary intravascular lithotripsy has increased substantially while the use of atherectomy has decreased. Unadjusted outcomes demonstrate high rates of procedural success and generally low rates of complications, particularly among patients undergoing elective PCI. Dr. Sukul’s co-authors are Ryan Madder, Babar Mir Basir, Dan Menees, Amir Kaki, Lorenzo Azzalini, and Hitinder S. Gurm.